The Radiant Creations Group (Radiant) (Trading Symbol-RCGP) develops and markets unique and proprietary scientific technologies,and cosmetic and over-the-counter personal enhancement product and devices. These products use both new technologies and ingredients, such as herbal extracts from the centuries of proven Traditional Chinese Medicine. Dr. Yin-Xiong Li, M.D. Ph.D., world-renowned geneticist and a Chief Medical Officer in China, is the chief scientific advisor to Radiant, and has developed or enhanced most of the company’s products. Radiant acquired an exclusive license agreement for Dr. Li’s patented and trade secret technologies; a patent for “Enhanced Broad – Spectrum UV Radiation Filters and Methods” an improvement application for DNA protection from UV radiation, an anti-aging skin rejuvenation cream, an acne over-the-counter treatment, a wrinkle reduction cream, and nutritional supplements for BioSalt redistribution technology for liver health, hypertension, and weight control. The asset transaction included the transfer of the licensing agreement, inventory, and other related intellectual property from The Renewable Corporation.
The comprehensive asset acquisition includes innovative technologies in skin protection from the sun, industrial UV sources (such as welding), and reducing collateral damage from medical radiation treatment. The patented technology strips out the four nucleotide code molecules from DNA strands and uses them in a system that can provide up to 99% protection from DNA damage from high energy UV light, which is the major cause of aging and skin cancer.
The harmful effects of sunburn are well known, but exposure to the UV radiation in sunlight does more than just damage the surface of the skin. DNA damage, such as free radicals, oxidative stress, and mutational changes can lead to cancer and other serious conditions. Many sunscreen products currently in use do not provide sufficient protection; in fact, some contain ingredients that break down under UV radiation and form chemicals that actively damage the skin.
With dangerous new levels of UV-B radiation now reaching the surface of the earth due to atmospheric damage, the risk of radiation exposure has increased exponentially. In addition, the technology can be used for increased protection in the workplace, in medical treatment radiation exposure to Beta and Gamma rays, and other opportunities in the industrial and architectural markets.
A second technology is the delivery system to house the nucleotides, and also a hydration agent that is time released to infuse uniform hydration in the skin for up to eight hours. The enhanced skin hydration level “off loads” the skin’s repair mechanisms, freeing them to work on repairing other imperfections, resulting in significant anti-aging and rejuvenation benefits.
The resulting products from these two technologies are a nucleotide based SPF-30 sunblock; an anti-aging and rejuvenating cream featuring the hydration system, Chinese herbs, and aloe; a medical radiation protection and healing cream for use by dermatologists in radiation therapy for skin cancer, and a rejuvenating nucleotide protection cream for the tanning bed industry, for DNA damage protection. The asset acquisition allows Radiant to capitalize on multiple scientific breakthroughs with remarkable potential. These exciting discoveries for skin care are branded as the “Revivasol” skin care line.
A second product line is BioSalts, an innovative product line for the dietary supplement market. The BioSalts products have been formulated using an exclusive combination of natural Chinese herbal ingredients with advanced technologies utilizing molecular elements that help regulate energy homeostasis to promote various positive health benefits such as fat burning, weight loss, weight control, increased energy, enhanced sleep, tissue regeneration and lower blood pressure. The technology as a supplement also promotes liver health.